Technology
Karolinska Development’S Portfolio Company Umecrine Cognition Presents New Preclinical Parkinson’S Data On Golexanolone At The Scientific Conference, INBC 2024
(MENAFN - GlobeNewsWire - Nasdaq) STOCKHOLM, SWEDEN – October 17, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition will present ...
By: menafn
- Oct 17 2024
- 0
- 0 Views
Share this page
Guest Posts by Easy Branches
